2seventy bio, Inc.
NASDAQ:TSVT
3.14 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 13.534 | 8.967 | 12.435 | 10.684 | 12.034 | 36.048 | 41.621 | 56.177 | 13.408 | 13.482 | 8.429 | 16.033 | 19.257 | 7.328 | 11.901 | 9.905 | 18.434 | 109.891 | 109.891 |
| Cost of Revenue
| 5.768 | 3.453 | 6.606 | 6.177 | 4.959 | 4.517 | 4.295 | 15.325 | 0.377 | 4.654 | 5.863 | 0.405 | 0.32 | 10.158 | 1.704 | 1.499 | 1.318 | 78.956 | 78.956 |
| Gross Profit
| 7.766 | 5.514 | 5.829 | 4.507 | 7.075 | 31.531 | 37.326 | 40.852 | 13.031 | 8.828 | 2.566 | 15.628 | 18.937 | -2.83 | 10.197 | 8.406 | 17.116 | 30.936 | 30.936 |
| Gross Profit Ratio
| 0.574 | 0.615 | 0.469 | 0.422 | 0.588 | 0.875 | 0.897 | 0.727 | 0.972 | 0.655 | 0.304 | 0.975 | 0.983 | -0.386 | 0.857 | 0.849 | 0.929 | 0.282 | 0.282 |
| Reseach & Development Expenses
| 8.32 | 16.013 | 41.824 | 48.187 | 51.315 | 59.98 | 68.246 | 49.312 | 61.739 | 68.439 | 69.245 | 59.544 | 61.131 | 63.692 | 77.571 | 68.882 | 72.253 | 77.666 | 77.666 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 12.884 | 9.857 | 12.659 | 16.201 | 13.004 | 19.489 | 20.72 | 18.701 | 19.61 | 17.278 | 23.861 | 24.48 | 22.996 | 21.402 | 24.627 | 21.946 | 22.105 | 23.424 | 23.424 |
| Other Expenses
| 0.503 | 0 | 0.646 | -0.534 | 2.704 | 2.812 | 2.643 | 2.561 | -0.624 | -0.644 | 4.762 | 7.309 | 5.237 | 3.929 | 5.174 | 4.744 | 4.339 | 0 | 0 |
| Operating Expenses
| 21.707 | 24.194 | 54.483 | 64.388 | 64.319 | 79.469 | 88.966 | 68.013 | 81.349 | 85.717 | 93.106 | 84.024 | 84.127 | 85.094 | 102.198 | 90.828 | 94.358 | 16.556 | 16.556 |
| Operating Income
| -13.941 | -20.356 | -48.654 | -59.881 | -77.968 | -47.991 | -51.64 | -27.161 | -68.318 | -76.889 | -90.54 | -68.371 | -65.238 | -87.971 | -92.37 | -81.545 | -76.414 | 7.512 | 7.512 |
| Operating Income Ratio
| -1.03 | -2.27 | -3.913 | -5.605 | -6.479 | -1.331 | -1.241 | -0.483 | -5.095 | -5.703 | -10.741 | -4.264 | -3.388 | -12.005 | -7.762 | -8.233 | -4.145 | 0.068 | 0.068 |
| Total Other Income Expenses Net
| 4.008 | 45.235 | -4.019 | 3.059 | -14.394 | 5.902 | 4.619 | 4.001 | 0.439 | -0.514 | 4.829 | 7.42 | 5.237 | 3.882 | 4.805 | 4.744 | 5.167 | 6.868 | 6.868 |
| Income Before Tax
| -9.933 | 24.879 | -52.673 | -56.822 | -71.638 | -42.089 | -47.021 | -23.16 | -67.879 | -77.403 | -85.711 | -60.974 | -60.001 | -84.042 | -87.196 | -76.801 | -72.075 | 14.38 | 14.38 |
| Income Before Tax Ratio
| -0.734 | 2.775 | -4.236 | -5.318 | -5.953 | -1.168 | -1.13 | -0.412 | -5.063 | -5.741 | -10.169 | -3.803 | -3.116 | -11.469 | -7.327 | -7.754 | -3.91 | 0.131 | 0.131 |
| Income Tax Expense
| 0 | 0 | 2.064 | -9.515 | 17.098 | -3.037 | -4.546 | -0.017 | -0.439 | 0.017 | -4.781 | -3.648 | 0.048 | 0.047 | 0.369 | 23.647 | -0.828 | 0 | 0 |
| Net Income
| -9.933 | 24.879 | -52.673 | -56.822 | -71.638 | -42.089 | -42.475 | -23.143 | -67.44 | -77.42 | -80.93 | -60.974 | -60.001 | -84.042 | -87.196 | -76.801 | -72.075 | 14.38 | 14.38 |
| Net Income Ratio
| -0.734 | 2.775 | -4.236 | -5.318 | -5.953 | -1.168 | -1.021 | -0.412 | -5.03 | -5.742 | -9.601 | -3.803 | -3.116 | -11.469 | -7.327 | -7.754 | -3.91 | 0.131 | 0.131 |
| EPS
| -0.19 | 0.48 | -1.01 | -1.11 | -1.4 | -0.83 | -0.98 | -0.6 | -1.75 | -2.02 | -3.03 | -2.59 | -2.58 | -3.61 | -3.74 | -3.3 | -3.1 | 0.617 | 0.617 |
| EPS Diluted
| -0.19 | 0.45 | -1.01 | -1.11 | -1.4 | -0.83 | -0.98 | -0.6 | -1.75 | -2.02 | -3.03 | -2.55 | -2.58 | -3.61 | -3.74 | -3.3 | -3.1 | 0.617 | 0.617 |
| EBITDA
| -11.78 | -18.249 | -46.547 | -56.851 | -54.482 | -45.7 | -49.385 | -24.836 | -65.941 | -73.588 | -87.01 | -64.861 | -60.523 | -83.452 | -88.325 | -80.075 | -73.904 | 10.778 | 10.778 |
| EBITDA Ratio
| -0.87 | -2.035 | -3.743 | -5.321 | -2.805 | -1.266 | -1.185 | -0.441 | -4.914 | -5.452 | -10.317 | -4.268 | -3.14 | -11.382 | -7.391 | -5.599 | -4.054 | 0.098 | 0.098 |